In the past 5-10 years there has been a growing trend for substituting conventional 5-fluorouracil with the oral prodrug of 5-fluorouracil, capecitabine, in chemotherapy regimens. This regimen change is based on evidence of the efficacy equivalence of these two drugs and the lack of an increase in overall toxic effects when capecitabine is used. Many investigators in different parts of the world have determined their own starting dose for capecitabine, usually based on their experience of tox...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Capecitabine: have we got the dose right?
If you are the owner of this record, you can report an update to it here: Report update to this record